Comparing Therapeutic Efficacy and Safety of Epoetin Beta and Epoetin Alfa in the Treatment of Anemia in End-Stage Renal Disease Hemodialysis Patients

BACKGROUND: Anemia is one of the most prevalent complications in patients with chronic kidney disease, which is believed to be caused by the insufficient synthesis of erythropoietin by the kidney. This phase III study aimed to compare the efficacy and safety of CinnaPoietin® (epoetin beta, CinnaGen)...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Am J Nephrol
Glavni autori: Azmandian, Jalal, Abbasi, Mohammad Reza, Pourfarziani, Vahid, Nasiri, Amir Ahmad, Ossareh, Shahrzad, Ezzatzadegan Jahromi, Shahrokh, Sanadgol, Hooshang, Amini, Somayeh, Shahvaroughi Farahani, Arshia
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2018
Teme:
Original Report: Patient-Oriented, Translational Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6381861/
https://ncbi.nlm.nih.gov/pubmed/30253403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000493097
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items